The homeostatic integrity of skin epidermis is maintained by a balance between keratinocyte proliferation, on one hand, and terminal differentiation combined with outward migration and shedding, on the other. Perturbation of this balance in favor of proliferation can result in hyperplasia and, potentially, tumorigenesis. We have previously described a reversible transgenic mouse model of epidermal neoplasia in which expression of an acutely regulatable form of Myc, MycER TAM , is targeted to epidermis via the involucrin promoter. In this model, sustained activation of MycER TAM induces a complex neoplastic lesion involving marked hyperplasia of lessdifferentiated suprabasal cells, angiogenesis and overt papillomatosis. Subsequent deactivation of MycER TAM triggers complete papilloma regression. Here, we provide evidence that Myc-induced papillomas are self-limiting because of the eventual differentiation of MycER TAM -expressing keratinocytes. Thus, keratinocyte differentiation eventually prevails over Myc-induced proliferation. We also show that regression of Myc-induced papillomas following MycER TAM deactivation occurs through a combination of growth arrest and irreversible differentiation. Finally, we demonstrate that transient deactivation of Myc is sufficient to expel keratinocytes irreversibly from the proliferative compartment and render them refractory to the mitogenic influence of subsequent Myc reactivation. Such observations illustrate the potential utility of even short-term inhibition of oncogenic lesions in the treatment of cancer.
The homeostatic integrity of skin epidermis is maintained by a balance between keratinocyte proliferation, on one hand, and terminal differentiation combined with outward migration and shedding, on the other. Perturbation of this balance in favor of proliferation can result in hyperplasia and, potentially, tumorigenesis. We have previously described a reversible transgenic mouse model of epidermal neoplasia in which expression of an acutely regulatable form of Myc, MycER TAM , is targeted to epidermis via the involucrin promoter. In this model, sustained activation of MycER TAM induces a complex neoplastic lesion involving marked hyperplasia of lessdifferentiated suprabasal cells, angiogenesis and overt papillomatosis. Subsequent deactivation of MycER TAM triggers complete papilloma regression. Here, we provide evidence that Myc-induced papillomas are self-limiting because of the eventual differentiation of MycER TAM -expressing keratinocytes. Thus, keratinocyte differentiation eventually prevails over Myc-induced proliferation. We also show that regression of Myc-induced papillomas following MycER TAM deactivation occurs through a combination of growth arrest and irreversible differentiation. Finally, we demonstrate that transient deactivation of Myc is sufficient to expel keratinocytes irreversibly from the proliferative compartment and render them refractory to the mitogenic influence of subsequent Myc reactivation. Such observations illustrate the potentialIntroduction Skin epidermis is a stratified epithelial tissue in which proliferation and differentiation are strictly compartmentalized. As cells detach from the basal lamina and leave the proliferating basal layer, they exit the cell cycle and migrate upwards into the suprabasal region, sequentially differentiating into spinous, granular and cornified strata. Maintenance of the epidermis requires a dynamic balance between cell gain, via proliferation of basal keratinocytes, and cell loss, via cell cycle arrest, differentiation and shedding. Excess proliferation over differentiation and shedding leads to hyperplasia and benign neoplasia, the presumed forbear of invasive cancers (Dotto, 1999) . Conversely, inadequate proliferation or excessive differentiation leads to a decrease in cellularity that may eventually result in loss of tissue integrity .
To model the effects of increased epidermal keratinocyte proliferation in vivo, we generated a mouse model in which expression of a reversibly switchable form of the Myc oncoprotein, MycER TAM , is targeted to epidermis using the involucrin promoter (Pelengaris et al., 1999) . Involucrin expression appears to initiate in the immediate suprabasal compartment, after which its expression is sustained throughout subsequent keratinocyte differentiation. When driven by the involucrin promoter, expression of MycER TAM is evident throughout the entire suprabasal compartment. Activation of suprabasal MycER TAM by topical administration of the ER TAM -activating ligand 4-hydroxytamoxifen (4-OHT) induces proliferation in the normally postmitotic immediate suprabasal layer, which tips the homeostatic balance in favor of cell expansion and results in progressive accumulation of suprabasal cells. In such hyperplastic lesions, proliferating cells extend well out into the suprabasal strata and terminal differentiation of keratinocytes appears delayed (Pelengaris et al., 1999) . So long as MycER TAM is kept active by repeated topical administration of 4-OHT, the hyperplasia evolves into a papillomatous epidermal lesion accompanied by profound dermal angiogenesis that resembles actinic keratosis (Pelengaris et al., 1999) . However, although the papillomas are continuously fed by new MycER TAM -expressing cells entering the base of the suprabasal compartment, the consequent papillomatotous lesions are self-limiting and benign because affected cells are continuously lost through outward migration and their eventual, although delayed, differentiation into quiescent granular, then cornified, cells. Subsequent deactivation of MycER TAM triggers rapid regression of papillomatous lesions together with associated dermal vasculature (Pelengaris et al., 1999) . Such observations intimate two important conclusions. First, although the keratinocyte differentiation program appears delayed, it nonetheless ultimately prevails over the ability of Myc to maintain suprabasal keratinocyte proliferation. This, in turn, implies that there is a stage of suprabasal keratinocyte differentiation beyond which cells become irreversibly refractory to the proliferative influence of Myc. One dramatic implication of this is that even temporary inhibition of Myc function might prove adequate to engage an irreversible keratinocyte differentiation program and permanently expel suprabasal tumor cells from the proliferative compartment, restoring the normal balance between cell gain and cell loss. In this paper, we explore these possibilities. We define the point of no return in keratinocyte differentiation beyond which keratinocytes become refractory to Myc action and then use the rapid reversibility of MycER TAM to determine directly the consequences of transient Myc deactivation for maintenance of established papillomas.
Results
Keratinocyte differentiation overwhelms Myc-driven proliferation in vivo
MycER
TAM was activated locally in skin keratinocytes of Inv-c-MycER TAM mice by topical application of 4-OHT in ethanol carrier to the shaved back of each animal daily for 14 days. Controls included nontransgenic mice treated topically with 4-OHT and InvMycER TAM transgenic mice treated with ethanol carrier alone, neither of which exhibited any discernible phenotype as expected (Pelengaris et al., 1999) . Sustained activation of Myc in suprabasal keratinocytes resulted in dramatic hyperplasia and pronounced papillomatosis within the treated area (Figure1a and Pelengaris et al., 1999) .
To define the differentiation status of the proliferating keratinocytes in MycER TAM -induced epidermal hyperplasia, serial sections of skin from control and 4-OHT-treated mice were then analysed immunohistochemically (IHC) for the presence and apposition of markers of proliferation and keratinocyte differentiation. In control interfollicular skin (either nontransgenic littermates or transgenic mice treated with ethanol carrier), Ki-67-positive proliferating cells were restricted exclusively to a fraction of cells within the basal layer (see Figure 3a) , while staining of the 'basal' marker K14 was evident throughout the basal layer, as predicted. Involucrin staining was barely detectable in the basal layer but intense throughout the suprabasal layer (Figure 3a) , as was staining of the other 'suprabasal' keratins K1 and K10 (not shown). Consistent with this established distribution of involucrin, we had previously shown that expression of MycER TAM (as detected by both anti-Myc and anti-ER TAM antibodies) was almost exclusively restricted to suprabasal, and not basal, cells (Pelengaris et al., 1999) .
In Inv-MycER TAM skin treated with 4-OHT for 14 days, staining of involucrin (and keratins 1 and 10 -not Figure 1 Myc-induced proliferation in suprabasal keratinocytes in vivo is highly dependent on their differentiation state. Adjacent sections of dorsal skin, from three Inv-MycER TAM mice treated daily and topically with 4-OHT (1 mg) for 2 weeks as described, were stained with hematoxylin and eosin (a) and probed with specific antibodies against Pan-Myc (b), involucrin (c), keratin 14 (d), p63 (e), Ki-67 (f) and BrdU (g). While expression of the transgene (b) and the differentiation marker involucrin (c) both increase towards the outer layers of the epidermis, expression of basal markers keratin 14 (d) and p63 (e), as well as the proliferation markers Ki-67 (f) and BrdU (g), all decrease towards the skin surface shown) was relatively weak in the inner layers of the hyperplastic epidermis but increased dramatically and progressively throughout the more differentiated granular layer, a pattern consistent with that observed in other instances of hyperplastic human and murine skin (Hertle et al., 1992; Li et al., 2000) . Moreover, Ki-67-positive and BrdU-staining proliferating cells were no longer confined exclusively to the basal layer but extended several layers into the suprabasal compartment although, importantly, not into the granular layer (compare panel a with panels f and g, Figure 1 ). Since expression of MycER TAM is driven from the involucrin promoter it is not surprising that it, too, increases as cells become more differentiated and enter the granular compartment ( Figure 1b) . Importantly, however, even though the elevated Myc is transcriptionally active in these more differentiated granular cells (as evidenced by 4-OHT-dependent expression of the Myc target gene ODC (Pelengaris et al., 1999) , such cells no longer proliferate. This implies that more-differentiated keratinocytes become refractory to the proliferative influence of Myc. K14 immunoreactivity within MycER TAM -induced epidermal hyperplasias was pronounced in the basal and immediately adjacent suprabasal layers, decreasing in intensity through to the granular layer -an essentially reciprocal distribution to that of involucrin (Figure 1c and d). K14 protein, however, has been shown to persist into the suprabasal compartment of hyperplastic epidermis despite the downregulation of K14 mRNA upon commitment to differentiation (Roop et al., 1988; Stoler et al., 1988; Waikel et al., 1999) . We therefore determined the expression of an alternative marker of basal keratinocytes, p63 protein, recently demonstrated to be more closely associated with the proliferative potential of keratinocytes and lost upon the transition from basal to suprabasal compartment (Parsa et al., 1999; Liefer et al., 2000; Pellegrini et al., 2001; Koster et al., 2004) . p63 staining was clearly evident in the basal and immediately adjacent suprabasal layers of MycER TAM -induced hyperplastic epidermis but abruptly lost as keratinocytes transitioned to the granular compartment, a distribution essentially coincident with that of both Ki67 and K14.
We conclude that the proliferating suprabasal keratinocytes in Myc-induced hyperplastic skin lesions in vivo exhibit a 'basal-like' phenotype that can be defined as Ki67 þ ; p63 þ ; K14 high; involucrin low; K1 and K10 low. Nonetheless, despite the sustained (indeed progressively increasing) presence of active Myc protein, keratinocyte differentiation still proceeds in vivo, eventually progressing to a point that precludes Myc-induced proliferation. This establishes a de facto stage in keratinocyte differentiation, between the immediate suprabasal and granular states, beyond which Myc looses its signature oncogenic capacity to drive cell proliferation. Thus, there is only a narrow window around the basal-suprabasal transition during which Myc is competent to drive suprabasal keratinocyte proliferation.
Mechanism of reversion of Myc-induced papillomas following Myc deactivation
We have previously demonstrated that the neoplastic lesions induced by activation of MycER TAM are completely reversible within approximately 3 weeks following Myc deactivation and regression involves loss of all supernumerary suprabasal keratinocytes, involution of attendant dermal angiogenesis and restoration of ostensibly normal skin architecture. However, the mechanism by which such regression occurs has not been determined. One possibility is that regression arises by apoptosis of the hyperplastic keratinocytes, either directly or indirectly through collapse of the underlying dermal vasculature as has been seen with switchable Myc models in other tissues (Jain et al., 2002; Pelengaris et al., 2002) . Alternatively, given the innate dynamics of skin epidermis, it is possible that the regression we see results from a combination of growth arrest and concomitant differentiation. To distinguish between these possibilities, Myc-induced papillomatous lesions were induced in cohorts of Inv-MycER TAM mice by sustained MycER TAM activation for 2 weeks. 4-OHT administration was then stopped and representative animals were killed at 2-day intervals over the ensuing 3 weeks to establish the architecture of papilloma regression.
To assess the extent and contribution of apoptosis to regression of papillomas following Myc deactivation, we used TUNEL staining (Figure 2 ). Fragmented DNA in apoptotic cells from sections of normal skin or from Myc-induced papillomas before and after Myc deactivation was end-labeled directly with fluorescein-conjugated dNTPs (shown in green), counterstained with propidium iodide (shown in blue) to identify cell nuclei, and assessed by fluorescence microscopy. Very low levels (o1%) of TUNEL-positive cells were observed in the interfollicular epidermis of both 4-OHT and control ethanol-treated mice. Consistent with other studies (Polakowska et al., 1994; Gandarillas et al., 1999) , all these TUNEL-positive cells were confined to the outermost (most differentiated) layers of the epidermis, especially where cells transitioned to the cornified layer. Enucleated cells within the cornified stratum itself did not stain with propidium iodide although they exhibited a low level of TUNEL staining, presumably due to the presence of residual fragmented DNA. Similarly, in MycER TAM -induced epidermal hyperplasia, TUNELpositive cells were confined to the outer layers, with substantial staining within the greatly thickened cornified stratum. Following Myc deactivation, occasional TUNEL-positive keratinocytes were detected within the interfollicular epidermis throughout the course of lesion regression. However, these were absent from the bulk of hyperplastic cells and, again, restricted to cells transitioning to the cornified layer. Taken together, these data indicate that elevated apoptosis plays no significant role in the rapid regression of Myc-induced papillomas upon Myc-deactivation.
To explore the role of growth arrest and differentiation in papilloma regression, we monitored keratinocyte proliferation, differentiation status and disposition immunohistochemically (Figure 3) . Surcease of 4-OHT led to rapid deactivation of MycER TAM accompanied by withdrawal from the cell cycle, as indicated by loss of Ki67 immunoreactivity. Interestingly, the outermost suprabasal layers arrested first, followed by the next outermost layer and so on until, by 6 days after 4-OHT withdrawal, Ki67 staining within the interfollicular epidermis was once again confined to cells within the basal layer, as it is in normal skin (Figure 3, panels b-e) . Loss of Ki67 immunoreactivity in suprabasal keratinocytes was accompanied by overt keratinocyte differentiation, as indicated by increase in cell size, granularity and involucrin staining. Within 2 days of 4-OHT withdrawal, we observed a significant increase in involucrin immunoreactivity, first evident in the outer suprabasal layers and, over the ensuing 4 days, progressing inwards through the hyperplastic suprabasal epidermis until, after 6 days, all but the innermost 2-3 layers were strongly positive for involucrin. Changes in p63 immunoreactivity were essentially reciprocal to that of involucrin. By day 6 of 4-OHT withdrawal, only the innermost 2-3 keratinocyte layers retained p63 immunoreactivity and this then persisted for at least the next 12 days, indicating that some characteristics of basal cells (i.e. p63 þ ; involucrin low) persist within this population for some time. This resembles the situation in normal epidermis wherein only a subset of basal cells Figure 2 Inactivation of Myc in hyperplastic skin does not appreciably increase the incidence of apoptosis. Shaved dorsal patches of skin of Inv-MycER TAM mice were treated topically with either ethanol carrier (a) or 4-OHT (1 mg) daily for 14 days. Administration of 4-OHT was then stopped and two mice from each cohort were killed immediately (b) or 2 (c), 4 (d), 6 (e), 10 (f), 14 (g), 17 (h) or 21 (i) days thereafter. Representative dorsal skin from each time point was fixed and paraffin embedded for sectioning. Sections (5 mm) were assessed for apoptosis by TUNEL (in green) and counterstained with propidium iodide (in blue) stain positively for Ki67 although all are positive for p63 ( Figure 3a) . As regression further proceeded over the ensuing second and third weeks, the number of granular cells progressively fell as they transitioned into the cornified layer, eventually to be sloughed off and lost (Figure 3 , panels f-i).
Differentiation following Myc deactivation rapidly renders keratinocytes refractory to Myc oncogenic action
Taken together, our data strongly suggest that papilloma regression following Myc deactivation arises through a combination of growth arrest and loss of supernumerary keratinocytes via ongoing terminal keratinocyte differentiation and outward migration.
Since we had already established that more differentiated suprabasal keratinocytes are refractory to Mycinduced proliferation, we next asked whether the exit of papillomatous keratinocytes from the cell cycle induced by Myc deactivation may be reversed by subsequent reactivation of MycER TAM .
Deactivation of MycER
TAM leads to growth arrest of all hyperplastic suprabasal keratinocytes within 5-6 days ( Figure 3) . Accordingly, papillomatous lesions were induced in Inv-c-MycER TAM mice by activating MycER TAM for 14 days (Figure 4a ) and MycER TAM then deactivated by surcease of 4-OHT administration for 5 days (Figure 4b ). Mice were then either killed immediately or the affected area of dorsal skin then retreated with continuous daily topical 4-OHT for an additional 3 or 6 days (Figure 4c and d ). An additional cohort of mice received 20 days of daily 4-OHT treatment (Figure 4e ). The relevant area of skin from each class of mouse was then subjected to IHC analysis for Ki67, p63, involucrin and BrdU incorporation to examine epidermal architecture and the status of keratinocyte proliferation and differentiation.
As expected, after 5 days of MycER TAM deactivation, all suprabasal keratinocytes had undergone proliferative arrest, as determined by absence of staining with Ki-67 antibody or BrdU incorporation. At this time, p63 staining was evident in the basal layer but also extended 2-3 layers into the suprabasal compartment, identifying this as a transient, nonproliferating population with 'basal' characteristics (p63 þ ; involucrin low). Subsequent reactivation of MycER TAM for an additional 3 or 6 days again resulted in the reappearance of Ki67 immunoreactivity within the suprabasal compartment. However, essentially, all such staining was confined to the keratinocyte layers immediately adjacent to the basal layer and was absent from the previously expanded suprabasal population. p63 immunoreactivity also increased in retreated epidermis and, significantly, continued to extend 2-3 cell layers further into the suprabasal compartment than that of Ki67. We conclude that p63-positive, Ki67-negative basal-like keratinocytes resulting from the deactivation of Myc are unable to re-enter the cell cycle upon MycER TAM reactivation and, instead, are progressively displaced upwards by the replenishing progeny of the proliferating basal cells below. Thus, the exit from the cell cycle elicited upon removal of MycER TAM stimulation is irreversible and constitutes a 'point of no return' in keratinocyte differentiation beyond which the cells become irreversibly refractory to the proliferative action of Myc.
Discussion
We have previously shown that acute activation of a switchable form of Myc, targeted primarily to suprabasal skin using the involucrin promoter, is alone sufficient to induce a complex papillomatous lesion involving dramatic accumulation of poorly differentiated keratinocytes, disorganization of normal Figure 3 Myc inactivation in hyperplastic skin results in tumor regression by spontaneous differentiation of supernumerary keratinocytes. Myc-dependent neoplasias were induced for 14 days by daily topical application of 4-OHT to shaved dorsal patches. Daily administration of 4-OHT was then stopped to deactivate Myc and skin harvested from mice killed after 2, 4, 6, 10, 14, 17 and 21 days. Adjacent sections to those used in Figure 2 were probed for expression of involucrin, p63 and Ki-67. Immunohistology indicates that papilloma regression involves the rapid cell cycle exit of affected keratinocytes and their progressive loss by spontaneous differentiation, outward migration and shedding epidermal structure and profound angiogenesis in the dermis underlying the papilloma (Pelengaris et al., 1999) . Subsequent deactivation of Myc leads to rapid and complete regression of such lesions, indicating that Myc provides functions necessary not only for papilloma formation but also for its maintenance (Pelengaris et al., 1999) . Myc is a highly pleiotropic transcription factor capable of modulating multiple cellintrinsic functions such as growth, metabolism, proliferation, apoptosis and differentiation, as well as cell extrinsic functions such as angiogenesis and invasion (Pelengaris et al., 1999 (Pelengaris et al., , 2002 . While it is generally accepted that the ability of Myc to drive cell proliferation underpins its well-documented role in driving tumorigenesis, the contribution of its other diverse attributes to tumor formation and tumor maintenance remains less well defined. The rapid and reversible switchability of the MycER TAM system offers a unique tool with which to determine how the different attributes of Myc play out over time within a specific intact tissue or cell type in vivo.
Detailed immunohistochemical analysis of Myc-induced epidermal hyperplasias in Inv-MycER TAM mice indicates that Myc activation in early suprabasal keratinocytes induces cell proliferation. Since involucrin (and hence Inv-MycER TAM ) is induced so early in the basal-suprabasal transition, it remains possible that it is even expressed at low level in basal keratinocytes (Schweizer et al., 1984; Watt, 1984; Regnier et al., 1986; Huitfeldt et al., 1991) . Consequently, it is not possible to say whether involucrin-driven Myc acts to retain incipient suprabasal cells in cycle or instead to induce their re-entry. Possibly, the molecular switching responsible for the transition is sufficiently indistinct for both to occur. Whichever, the result is the rapid accumulation of excess suprabasal cells that initially retain significant basal attributes but then proceed to differentiate despite sustained (indeed, increasing) Myc Figure 4 Brief Myc inactivation permanently expel neoplastic keratinocytes from their proliferation compartment. After 14 days of continuous MycER TAM activation (a), administration of 4-OHT was stopped for 5 days (b). MycER TAM was then reactivated by daily topical 4-OHT administration for the next 3 (c) or 6 (d) days. As a control, Inv-MycER TAM mice were treated with 4-OHT for 20 (14 þ 6) consecutive days with no interlude (e). At the indicated times, representative dorsal skin samples were fixed, paraffin embedded and consecutive sections probed immunostained for involucrin, p63 and Ki-67. Keratinocytes in S phase were identified by staining for incorporated BrdU. At least two Inv-MycER TAM mice were analysed at each time point activity, eventually withdrawing from the cell cycle as they enter the granular compartment. The end result is significant expansion of the entire differentiated suprabasal compartment, which reconciles our data with the surprising conclusion reached by others (Gandarillas and Watt, 1997; Arnold and Watt, 2001 ) that Myc appears to promote keratinocyte differentiation. As in normal skin, the basal compartment of Inv-MycER TAM mouse skin continues to proliferate and generate new suprabasal cells throughout. The consequent continuous displacement outward of the hyperplastic suprabasal population, together with terminal differentiation at the luminal side, generates a self-limiting hyperplasia that manifests as a benign papillomatous lesion. It is of note that activation of Myc in intact skin epidermis, unlike many other in vitro and in vivo settings, does not result in 'compensatory' apoptosis. This is most probably because of an abundance local survival factors in skin (Pelengaris et al., 1999) and underscores how dependent the net biological impact of Myc activation is on cell context and type.
Given the dynamics of skin epidermis, it is not possible to distinguish whether Myc acts solely to extend the window of suprabasal keratinocyte proliferation or whether it also delays differentiation of keratinocytes in which it is expressed. Nonetheless, these same dynamics suggest a likely mechanism for regression of papillomas following deactivation of Myc in which the expanded suprabasal cells drop out of cycle and their spontaneous differentiation eventually leads to their loss by shedding at the surface. We confirmed this hypothetical mechanism through detailed immunohistochemical analysis of skin at various times after MycER TAM deactivation, which showed rapid proliferative arrest of hyperplastic suprabasal keratinocytes, succeeded by their differentiation, outward migration and loss. The negligible level of apoptosis detected throughout the entire period of regression further supports the conclusion that regression occurs by a combination of proliferative arrest, terminal differentiation and shedding, rather than by apoptotic death of supernumerary cells.
Having shown that keratinocytes become refractory to the mitogenic actions of Myc once they have differentiated into granular cells, this raised the possibility that even transient deactivation of MycER TAM might prove sufficient to allow cells to progress into the granular keratinocyte compartment where they would become irreversibly excluded from the proliferative compartment. As predicted, deactivation of Myc for 5 days, sufficient time to allow all hyperplastic suprabasal keratinocytes to withdraw from the cell cycle, rendered all such cells refractory to the proliferative actions of reactivated MycER TAM . This observation is in broad accord with that of Jain, who also recently showed in a transplanted osteosarcoma model that transient deactivation of Myc is sufficient to induce tumor regression (Jain et al., 2002) . In their case, Myc deactivation induces differentiation of osteosarcoma cells into osteocytes and subsequent reactivation of Myc triggers osteocyte apoptosis. In contrast, reactivation of Myc in differentiated suprabasal keratinocytes has no such negative effect on their viability although, of course, such cells are destined to die anyway by terminal differentiation and shedding. However, these profound differences between osteocytes and keratinocytes indicate that the biological consequences of Myc reactivation depend greatly on the specific cell lineage, and developmental position within that lineage, where Myc deactivation and subsequent reactivation occur. This is most graphically demonstrated by the dramatic difference in the apparent dependency upon Myc activity for tumor maintenance in our Inv-MycER TAM skin model versus the K14-driven skin MycER TAM model recently described in which MycER TAM expression is targeted to the basal keratinocyte population (Arnold and Watt, 2001 ). In this model, even transient activation of MycER TAM appears sufficient to provoke a sustained hyperplastic lesion, presumably because a one-off activation of Myc in the basal compartment triggers expansion of basal keratinocyte population that then feeds a persistent expanded population of downstream transit cells.
Nonetheless, compelling evidence is emerging that tumor cells are in effect 'addicted' to the oncogenic pathways that drive their tumorigenesis. In some cases, this is because oncogenic pathways such as Myc are required to overcome the growth inhibitory effects of other oncogenic mutations present within the tumor cell (Evan and Littlewood, 1998; Evan and Vousden, 2001) . In other cases, sustained activation of oncogenic proliferative pathways appears to be required to maintain tumor vasculature (Chin et al., 1999; Pelengaris et al., 2002) . Both our own model and that of Jain et al. demonstrate the potent therapeutic potential of transient inactivation or inhibition of critical oncogenic lesions in those cell lineages where spontaneous differentiation then renders the affected cell impervious to further oncogenic action, either through refractoriness or induction of cell death. In tumors arising in such tissues, such transient inhibition of proliferative pathways may therefore exert a profound therapeutic effect on a tumor while causing relatively little pathology in normal tissues. Exploiting this aspect of 'oncogenic addiction' offers a novel and useful strategy for the future treatment of cancer.
Materials and methods

Animals and treatment regimens
Generation and characteristics of the Inv-MycER TAM mice have been described previously (Pelengaris et al., 1999) . The mice used in this study were bred into a CBA/Bl6 mixed genetic background. MycER TAM was activated in skin of 8-12-week-old transgenic mice by daily topical administration of 4-Hydroxytamoxifen (Sigma, 1 mg dissolved in 0.2 ml ethanol) to a shaved area (approx. 4 cm 2 ) of dorsal skin. For systemic labeling of S-phase cells, mice received an i.p. injection of 400 ml BrdU (10 mM in saline) 4 h prior to the killing.
Histology and immunohistochemistry (IHC) of mouse skin
Skin samples from transgenic mice were fixed overnight in neutral-buffered formalin at 41C, dehydrated through graded alcohols and xylene, and embedded in paraffin. Adjacent 5 mM sections were used for histological analysis, either for IHC or staining with hematoxylin and eosin. Prior to IHC, slides were deparaffinized, rehydrated, immersed in 10 mM citrate solution and epitopes retrieved by three high-power, 5 min microwave pulses. Slides were washed in water, blocked in 1 : 10 dilution of normal goat serum (Vector Labs) and incubated with primary antibodies: rabbit polyclonal antibody against Myc (Pan-Myc) at 1 : 1000 dilution (Moore et al., 1987) , involucrin at 1 : 500 (BabCO), or keratin 14 at 1 : 200 (BabCO), and murine monoclonal antibody to p63 at 1 : 200 (4A4, Santa Cruz) or Ki-67 at 1 : 200 (kindly provided by Dr Jeffrey Arbeit, Washington University). They were then incubated with secondary biotinylated antibodies from Vector labs (goat anti-rabbit at 1 : 200 or goat anti-mouse at 1 : 200), followed by signal development with an immunoperoxidase reagent (ABC-HRP, Vector Labs) and DAB (Sigma) as the substrate.
Sections were lightly counterstained with hematoxylin and analysed by light microscopy.
TUNEL assay for apoptosis
TUNEL staining was performed using the Apoptag direct end-labeling protocol (Serologicals Corp.). Briefly, 5 mm paraformaldehyde-fixed, paraffin-embedded sections were deparaffinized and treated with proteinase K (20 mg/ml) for 15 min at room temperature, equilibrated, then incubated with Terminal Deoxynucleotidyl Transferase in the presence of fluoresceinlabeled dNTPs for 1 h at 371C. Slides were subsequently incubated 15 min in stop buffer, blotted dry and counterstained with propidium iodide (1 mg/ml) in fluorescent mounting media (DAKO Corp.).
